Novartis News, Novartis Quote, NVS Quote

Novartis (NY:NVS) Delayed: 137.48 -22.51 (14.07%)

Prev. Close

$159.99

Today 6M 1Y 5Y

Open

$139.94

52 Wk High

$89.15

52 Wk Low

$69.84

Day High

$140.46

Day Low

$137.47

P/E

N/A

EPS

$0.00

Volume

6,560,511

Friends, Peers and Foes (?): NOVN:SW, NOVN, MRK, NVO, SNY (more...)

ALERTS | RSS

Sep 8, 2026 06:09 AM Novartis DM1 drug trial misses primary endpoint in Phase III study
Sep 8, 2026 06:05 AM Form 6-K NOVARTIS AG For: Sep 08
Sep 8, 2026 05:38 AM Novartis (NOVN:SW) (NVS) PT Raised to CHF130 at Barclays
Sep 8, 2026 05:27 AM Novartis (NVS) call put ratio 1.6 calls 1 put into share price lower before the bell
Sep 4, 2026 05:22 PM Form 6-K NOVARTIS AG For: Sep 04
Sep 4, 2026 04:52 PM Novartis pelacarsen trial fails to meet primary endpoint
Sep 4, 2026 06:06 AM Novartis (NOVN:SW) (NVS) PT Raised to CHF150 at BofA Securities
Sep 1, 2026 06:38 AM Premarket movers: GoPro soars 80% as Sono Group soars on Sports One deal
Sep 1, 2026 06:21 AM Form 6-K NOVARTIS AG For: Sep 01
Sep 1, 2026 06:04 AM Novartis MS drug remibrutinib meets Phase III trial goals

Entities mentioned with NVS

View All Entities